Search results
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com
ETF DAILY NEWS· 6 days agoBarclays lifted their target price on Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an “overweight” rating in a report on Tuesday, February 6th. Wolfe Research began coverage ...
Myriad Genetics (NASDAQ:MYGN) Hits New 52-Week High at $24.92
ETF DAILY NEWS· 6 days agoMyriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $24.92 and last traded at $24.45 ...
Natixis Advisors L.P. Sells 248 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
ETF DAILY NEWS· 6 days agoNatixis Advisors L.P. cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with ...
SyndBuddy AI By Joshua Zamora, Social Sharing & Lead Generation Software Launch
Digital Journal· 3 days ago...In New Report San Mateo-Based Pets Benefit From Dog Walking Services Provided by PAWS Dog Camp Salt River Therapy Is Glad to Announce the Addition of a New Associate Therapist Organic Treats for Dogs In Salmon, Minty & Fruity Variants Launched...
Zurcher Kantonalbank Zurich Cantonalbank Sells 1,854 Shares of Pliant Therapeutics, Inc....
ETF DAILY NEWS· 6 days agoZurcher Kantonalbank Zurich Cantonalbank lessened its holdings in shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 24.9% in the fourth quarter, according to the company in ...
Leerink Partnrs Comments on LENZ Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:LENZ)
ETF DAILY NEWS· 4 days agoLENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Equities research analysts at Leerink Partnrs increased their Q2 2024 EPS estimates for shares of LENZ Therapeutics in a research report ...
Natixis Advisors L.P. Buys 4,941 Shares of Glaukos Co. (NYSE:GKOS)
ETF DAILY NEWS· 4 days agoNatixis Advisors L.P. raised its stake in Glaukos Co. (NYSE:GKOS – Free Report) by 14.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 38,920 shares ...
Arcus Biosciences (NYSE:RCUS) Shares Gap Up on Better-Than-Expected Earnings
ETF DAILY NEWS· 6 days agoShares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) gapped up before the market opened on Thursday following a stronger than expected earnings report. Arcus Biosciences shares last ...
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $13.67 Consensus Price Target from Brokerages
ETF DAILY NEWS· 5 days agoShares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat.com ...
How Nintendo Switch Is Being Used By A New Generation Of Therapists
Nintendo Life· 6 days agoToday, Tim speaks to therapists to discover how they are using Switch and video game therapy to help...